🇺🇸 Extended- release Oxycodone in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anorexia — 1 report (10%)
  2. Circumstance Or Information Capable Of Leading To Medication Error — 1 report (10%)
  3. Constipation — 1 report (10%)
  4. Dehydration — 1 report (10%)
  5. Drug Dispensing Error — 1 report (10%)
  6. Drug Prescribing Error — 1 report (10%)
  7. Headache — 1 report (10%)
  8. Ileus — 1 report (10%)
  9. Incorrect Dosage Administered — 1 report (10%)
  10. Loss Of Consciousness — 1 report (10%)

Source database →

Other Pain Management approved in United States

Frequently asked questions

Is Extended- release Oxycodone approved in United States?

Extended- release Oxycodone does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Extended- release Oxycodone in United States?

Hospital Central Dr. Luis Ortega is the originator. The local marketing authorisation holder may differ — check the official source linked above.